Teresa Heslop

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 300 citations

Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats

Andrew D. Medhurst, Michael A. Briggs, Gordon Bruton et al. · Biochemical Pharmacology · 2007 · 64 citations

Scopolamine-induced Memory Impairment, Medicine, Behavioural Pharmacology +7

Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)

Bruce E. Miller, Ruth J. Mayer, Navin Goyal et al. · British Journal of Clinical Pharmacology · 2017 · 53 citations · Full text

Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists

David M. Wilson, James Apps, Nicholas Bailey et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 25 citations · Full text

Molecular Pharmacology, Pharmacological Study, Clinical Candidates +7

Kinetic characterization of bile salt transport by human NTCP (SLC10A1)

Márton Jani, Erzsébet Beéry, Teresa Heslop et al. · Toxicology in Vitro · 2017 · 21 citations

Biochemistry, Biliary Tract, Medicine +7